RB1 and cancer: We demonstrated that the combination of Aurora kinase A inhibition and TRIP13 depletion causes extensive apoptosis selectively in retinoblastoma (RB1, Rb) deficient cancer cells, sparing Rb-proficient and non-transformed cells [20].